Michigan 2023-2024 Regular Session

Michigan Senate Bill SB0133

Introduced
3/2/23  
Refer
3/2/23  
Report Pass
9/28/23  
Refer
9/28/23  
Report Pass
10/5/23  
Engrossed
10/10/23  
Refer
10/10/23  
Report Pass
11/2/23  
Enrolled
11/9/23  
Chaptered
12/29/23  

Caption

Health: controlled substances; overdose fatality review act; create. Creates new act.

Impact

The implementation of SB 0133 is expected to significantly enhance the state’s approach to managing drug overdose fatalities. The bill stipulates that these multidisciplinary review teams will collect and assess data on overdose occurrences to inform strategies that could prevent future fatalities. It recognizes the importance of cooperation among different sectors, including health care, law enforcement, and social services, to tackle the complex issues surrounding substance use disorders more effectively. By establishing a structured process for review and intervention, the bill aims to reduce drug-related deaths through informed decision-making.

Summary

Senate Bill 0133 establishes the Overdose Fatality Review Act in the state of Michigan, aiming to address and prevent deaths related to drug overdoses. The bill mandates the formation of overdose fatality review teams at the county level, tasked with conducting reviews of individual overdose cases to identify systemic barriers to overdose prevention and intervention strategies. These teams will consist of various local officials, health providers, law enforcement, and other relevant professionals who will work collaboratively to analyze overdose incidents and recommend policy changes.

Sentiment

Overall, the sentiment surrounding SB 0133 appears to be positive among stakeholders who value the collaborative approach to addressing drug overdose prevention. Supporters argue that it reflects a responsive and proactive strategy that places public health at the forefront. However, discussions may also acknowledge some concerns regarding privacy and the handling of sensitive data collected during reviews, as the act imposes strict confidentiality measures to protect individual identities in the review process.

Contention

Some potential points of contention may arise surrounding the extent of data shared between agencies involved in overdose reviews, with concerns about the implications for patient confidentiality and the potential for misuse of sensitive information. Additionally, the effectiveness of such review teams and their recommendations in enacting real change in local policies and intervention strategies will likely be scrutinized. Ensuring that these reviews lead to actionable insights rather than merely compiling data will be essential for the long-term success of the initiative.

Companion Bills

No companion bills found.

Similar Bills

CA AB408

Physician Health and Wellness Program.

OR HB2929

Relating to substance use; declaring an emergency.

PA HB585

Providing for behavioral health response unit and crisis call center programs; establishing the County and Regional Behavioral Health Response Unit and Crisis Call Center Fund and the County and Regional Behavioral Health Response Unit and Crisis Call Center Grant Program.

IN SB0001

Behavioral health matters.

MI HB4522

Courts: other; family treatment court; create. Amends sec. 1082 of 1961 PA 236 (MCL 600.1082) & adds ch. 10D.

GA HB520

Buildings and housing; tenant selection; revise provisions